Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
2005 · New England Journal of Medicine · 5,324 citations
https://doi.org/10.1056/nejmoa052122
P
Peter A. Kaufman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
339
Papers
21.3K
Citations
60
h-index
130
i10-index
Peter A. Kaufman is an academic researcher from University of Vermont. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Cancer Treatment and Pharmacology. The author has an h-index of 60, co-authored 289 publications.
ORCID: 0000-0003-3677-6807Papers by this author
worksMONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
2017 · Journal of Clinical Oncology · 1,620 citations
https://doi.org/10.1200/jco.2017.73.7585
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
2020 · The Lancet Oncology · 865 citations
https://doi.org/10.1016/s1470-2045(19)30863-0
Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
2011 · Journal of Clinical Oncology · 712 citations
https://doi.org/10.1200/jco.2011.35.0868
Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial
2008 · Journal of Clinical Oncology · 541 citations
https://doi.org/10.1200/jco.2007.13.5467
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
2021 · Annals of Oncology · 370 citations
https://doi.org/10.1016/j.annonc.2021.09.015
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat